UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 558

Sortiert nach

Systemic Therapy for Metastatic Colorectal Cancer: Current Options, Current Evidence

Journal of clinical oncology, 2005-07, Vol.23 (20), p.4553-4560

2005

Volltextzugriff (PDF)

Pooled Safety and Efficacy Analysis Examining the Effect of Performance Status on Outcomes in Nine First-Line Treatment Trials Using Individual Data From Patients With Metastatic Colorectal Cancer

Journal of clinical oncology, 2009-04, Vol.27 (12), p.1948-1955

2009

Volltextzugriff (PDF)

Managing Older Patients With Colorectal Cancer

Journal of clinical oncology, 2007-05, Vol.25 (14), p.1891-1897

2007

Volltextzugriff (PDF)

What Can Be Learned From Crowdsourced Population Asparagus Urinary Odor Kinetics?

CPT: pharmacometrics and systems pharmacology, 2019-06, Vol.8 (6), p.407-414

2019

Volltextzugriff (PDF)

Long-Term Safety Evaluation of Continuous Intraocular Delivery of Aflibercept by the Intravitreal Gene Therapy Candidate ADVM-022 in Nonhuman Primates

Translational vision science & technology, 2021-01, Vol.10 (1), p.34-34

2021

Volltextzugriff (PDF)

Response of epithelioid haemangioendothelioma to liposomal doxorubicin

The lancet oncology, 2005-10, Vol.6 (10), p.813-815

2005

Volltextzugriff (PDF)

Integrated approach to collecting patient reported toxicities in a colorectal cancer trial

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.51-51

2022

Volltextzugriff (PDF)

Commercial vs. Medicaid insurance and use of high-priced anticancer treatments

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.6599-6599

2023

Volltextzugriff (PDF)

Reliability of claims-based measures used to assess cancer care quality

Journal of clinical oncology, 2021-10, Vol.39 (28_suppl), p.42-42

2021

Volltextzugriff (PDF)

Influence of social determinants of health on oncology care quality rankings

Journal of clinical oncology, 2021-10, Vol.39 (28_suppl), p.139-139

2021

Volltextzugriff (PDF)

Delivery of a Healthy Baby After First-Trimester Maternal Exposure to Lapatinib

Clinical breast cancer, 2006-10, Vol.7 (4), p.339-341

2006

Volltextzugriff (PDF)

Comparing FOLFOX delivery in trial and real-world populations using longitudinal cumulative dose

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.1521-1521

2021

Volltextzugriff (PDF)

Using randomized trial data to estimate effects of complex treatment regimens in real-world patients

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e18706-e18706

2021

Volltextzugriff (PDF)

Sa1916 REAL WORLD OUTCOMES OF A NOVEL FECAL MICROBIOME REPLACMENT TREATMENT FOR THE PREVENTION OF RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION: A MULTICENTER STUDY

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-578-S-579

2024

Volltextzugriff (PDF)

Enterococcus exceedances related to environmental variability at New Jersey ocean beaches

Environmental monitoring and assessment, 2023-01, Vol.195 (1), p.250, Article 250

2023

Volltextzugriff (PDF)

REDUCTIONS IN LDL-C WITHIN THE FIRST YEAR OF TREATMENT WITH INCLISIRAN: RESULTS FROM A MULTICENTER REAL WORLD COHORT

Journal of the American College of Cardiology, 2024-04, Vol.83 (13), p.1941-1941

2024

Volltextzugriff (PDF)

Comparative effectiveness of trimodal therapy versus definitive chemoradiation in older adults with locally advanced esophageal cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e16093-e16093

2022

Volltextzugriff (PDF)

A study of pembrolizumab (pembro) in combination with Y90 radioembolization in patients (pts) with poor prognosis hepatocellular carcinoma (HCC) with preserved liver function

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.422-422

2022

Volltextzugriff (PDF)

Effectiveness of adjuvant FOLFOX versus 5FU for colon cancer treatment in community oncology practice using a hybrid study approach

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.7067-7067

2020

Volltextzugriff (PDF)

Longitudinal cumulative dose: A novel measure to assess multiple dimensions of chemotherapy adherence over time

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.3522-3522

2020

Volltextzugriff (PDF)

A study of pembrolizumab (pembro) in combination with Y90 radioembolization in patients (pts) with poor prognosis hepatocellular carcinoma (HCC)

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.534-534

2023

Volltextzugriff (PDF)

Building a population management informatics infrastructure for oncology care

Journal of clinical oncology, 2019-09, Vol.37 (27_suppl), p.315-315

2019

Volltextzugriff (PDF)

Impact of brain metastases on end-of-life health care utilization

Journal of clinical oncology, 2019-09, Vol.37 (27_suppl), p.116-116

2019

Volltextzugriff (PDF)

Phase II single-arm study of palbociclib and cetuximab rechallenge in KRAS/NRAS/BRAF wild-type ( KRAS WT) metastatic colorectal cancer (mCRC) patients (pts)

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.88-88

2022

Volltextzugriff (PDF)

Impact of solid tumor brain metastases on end-of-life healthcare utilization

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e18373-e18373

2019

Volltextzugriff (PDF)

1 – 25 von 558

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(517)
Mit Volltextzugriff
(511)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Systemic Therapy for Metastatic Colorectal Cancer: Current Options, Current Evidence

Pooled Safety and Efficacy Analysis Examining the Effect of Performance Status on Outcomes in Nine First-Line Treatment Trials Using Individual Data From Patients With Metastatic Colorectal Cancer

Managing Older Patients With Colorectal Cancer

What Can Be Learned From Crowdsourced Population Asparagus Urinary Odor Kinetics?

Long-Term Safety Evaluation of Continuous Intraocular Delivery of Aflibercept by the Intravitreal Gene Therapy Candidate ADVM-022 in Nonhuman Primates

Response of epithelioid haemangioendothelioma to liposomal doxorubicin

Integrated approach to collecting patient reported toxicities in a colorectal cancer trial

Commercial vs. Medicaid insurance and use of high-priced anticancer treatments

Reliability of claims-based measures used to assess cancer care quality

Influence of social determinants of health on oncology care quality rankings

Delivery of a Healthy Baby After First-Trimester Maternal Exposure to Lapatinib

Comparing FOLFOX delivery in trial and real-world populations using longitudinal cumulative dose

Using randomized trial data to estimate effects of complex treatment regimens in real-world patients

Sa1916 REAL WORLD OUTCOMES OF A NOVEL FECAL MICROBIOME REPLACMENT TREATMENT FOR THE PREVENTION OF RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION: A MULTICENTER STUDY

Enterococcus exceedances related to environmental variability at New Jersey ocean beaches

REDUCTIONS IN LDL-C WITHIN THE FIRST YEAR OF TREATMENT WITH INCLISIRAN: RESULTS FROM A MULTICENTER REAL WORLD COHORT

Comparative effectiveness of trimodal therapy versus definitive chemoradiation in older adults with locally advanced esophageal cancer

A study of pembrolizumab (pembro) in combination with Y90 radioembolization in patients (pts) with poor prognosis hepatocellular carcinoma (HCC) with preserved liver function

Effectiveness of adjuvant FOLFOX versus 5FU for colon cancer treatment in community oncology practice using a hybrid study approach

Longitudinal cumulative dose: A novel measure to assess multiple dimensions of chemotherapy adherence over time

A study of pembrolizumab (pembro) in combination with Y90 radioembolization in patients (pts) with poor prognosis hepatocellular carcinoma (HCC)

Building a population management informatics infrastructure for oncology care

Impact of brain metastases on end-of-life health care utilization

Phase II single-arm study of palbociclib and cetuximab rechallenge in KRAS/NRAS/BRAF wild-type ( KRAS WT) metastatic colorectal cancer (mCRC) patients (pts)

Impact of solid tumor brain metastases on end-of-life healthcare utilization

Suchergebnisse filtern